Novak Djokovic and his wife hold a majority stake in a Danish biotech company which is aiming to develop a medical treatment to combat coronavirus, the firm’s chief executive has said.
QuantBioRes CEO Ivan Loncarevic revealed the news to Reuters on Wednesday. The Serbian star and his wife, Jelena, have a combined 80% share, with 40.8% owned by the tennis ace and 39.2% held by his spouse.
Loncarevic said the tennis world number one – who has amassed over $150 million in career prize money – made the investment in June 2020, but did not disclose the amount.
Copenhagen-based QuantBioRes is aiming to develop a ‘peptide’ treatment against Covid-19 which would inhibit the virus from infecting human cells.